期刊文献+

维吾尔族和汉族冠心病患者冠状动脉病变程度与危险因素的对照分析 被引量:6

下载PDF
导出
摘要 目的:探讨新疆维吾尔族和汉族冠心病(CHD)患者冠状动脉病变程度的差异与危险因素。方法:根据冠状动脉造影(CAG)确诊的冠心病住院患者分为维吾尔族CHD组(80例)和汉族CHD组(188例)。分析两组患者冠状动脉病变的特点并就高血压、糖尿病、超重、血脂紊乱等危险因素进行比较分析。结果:维吾尔族单支、双支和三支病变分别为38.75%,23.75%和37.50%,汉族组分别为46.28%,29.26%和24.47%。维吾尔族CHD组超重患者明显高于汉族组(P<0.01),血脂紊乱患者中,低高密度脂蛋白(HDL-C)患者明显高于汉族组(P<0.05)。结论:维吾尔族CHD患者以三支病变为多,维、汉两组危险因素相比维吾尔族超重、低HDL-C是最主要的危险因素。
出处 《新疆医学》 2007年第2期9-12,共4页 Xinjiang Medical Journal
  • 相关文献

参考文献15

  • 1吴兆苏 姚崇华 赵冬 等.11省队列人群心血管发病前瞻性研究(个体危险因素聚集与心血管病发病的关系).中华心血管病杂志,2001,29(4):266-266.
  • 2Gorld KL,Lipecomb K,Halmilton GW.Physiologu basis for assessing critical coronary stenosis:instantaneous flow respouse and regional distribution during coronary hyperemia as measure of coronary flow reserve.Am J Cardiol,1974; 33:87 -91.
  • 3Guidelines Subcommittee of the WHO-TSH Mild Hypertension.Liaison Committee 1999 World Health organization-international society of hyher-tersion guildelinea for the management of hypertension.Hypertenion,1999; 17:151.
  • 4方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 5Helsiniki Heart Study:Prevention with Gemfibrozilin middle-aged men with dyslipidemia.N Engl J.Med,1987; 317(20):137.
  • 6邵耕.现代心脏病学.北京:北京医科大学、协和医科大学联合出版社,1994,71-78.
  • 7马依彤,刘宇,汤宝鹏,程祖亨,张爱伦,王疆,张燕一.新疆维吾尔族与汉族冠状动脉造影对比分析[J].中国介入心脏病学杂志,2001,9(4):211-212. 被引量:31
  • 8何秉贤,张建义.乌鲁木齐心血管病人监测1985年小结.第二届西北几省心血管会议汇编,1986,1-10.
  • 9Eckel RH,for the nutrition committee:obesity and heart disease.A statement for healthcare professionals from the nutrition committee.American Heart Association.Criculation,1997;96:3248-3250.
  • 10周祖文.冠心病主要危险因素研究的一些进展[J].蛇志,2002,14(2):56-59. 被引量:3

二级参考文献36

  • 1王用智.心血管疾病危险因素控制[J].医学综述,2001,7(8):480-482. 被引量:6
  • 2刘国仗,齐建华.高血压研究的进展[J].中国慢性病预防与控制,1996,4(5):193-194. 被引量:10
  • 3陈国伟 郑宗鄂.现代心脏病学[M].长沙:湖南科学技术出版社,1995.928.
  • 4[1]Judkins MP. Selective coronary angiography A percutaneous transfemoral technique. Radiology, 1967,89:815-820.
  • 5[2]Amplatz K, formanck G, Stranger P, et al. Mechanics of coronary artery catheterization via femoral approach. Radiology, 1967,89:1040-1042.
  • 6[3]Guld KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol, 1974,33:87-91.
  • 7[5]ACC/AHA Task Force. Guidelines for percutaneous transluminal coronary angioplasty. A Report of the American College of Cardiology/ American Heart Association Task Force on assessment of Diagnostc and Therapeutic Cardiovascular Procedures (Subcommittee on PLCA). J Am Coll Cardiol, 1988,12:529-531.
  • 8Nakamura Y, Yokoi Y, Hamaguchi H, et al. Importance of Lipoprotein in patients with Ischemic heart disease[J]. J Cardiol,1992,22(2-3):319-323.
  • 9Kugiyama K, Doi H, Takazoc K, et al. Remnant Lipoprotein Levels in fasting serum predict coronary events in patients with coronary artery disease[J]. J Circulatlon,1999,99(22):2858-2860.
  • 10Kohler E, Bentrup A, Funke H, et al. Relatonship between lipid metabolism disorders and age of fist manifestations of coronary heart disease[J]. Z Kardiol, 1992, 81(7) :354-360.

共引文献3111

同被引文献47

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部